Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-01

FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approves a supplemental application for oxcarbazepine submitted by Amneal Pharmaceuticals LLC for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)